ArticleJMIR public health and surveillance2025
Small-Area Lung Cancer Incidence and Mortality: Cross-Sectional Population-Based Study Using Hospital Discharge and Death Registration Data.
Article in JMIR public health and surveillance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Despite rapid development, cancer registries in low- and middle-income countries, such as China, have the persistent problems with up to 6-year delay and a lack of reported details about small areas. Objective: This study aimed to develop an approach to provide more up-to-date localized cancer surveillance using linked administrative data. We used lung cancer as an example. Methods: Based on data of hospitalization record front pages (HRFPs) between 2013 and 2022 from all the secondary and tertiary hospitals in Shandong Province, China, we identified incident cases of lung cancer in 2022 with 2013-2021 being the washout period. Deaths from lung cancer were ascertained for 2022 using linked HRFPs and death registration data. We estimated age-standardized incidence and mortality rates (ASIR and ASMR) of lung cancer in 2022 using Segi world standard population, age-specific incidence and mortality rates by sex, and county-level ASIR and ASMR to illustrate regional disparity. We grouped the counties by municipalities and calculated the Theil indices for within-municipality inequality and between-municipality inequality. Results: The HRFPs captured 79,672 incident cases of lung cancer in Shandong in 2022 (45,527 males, 34,145 females). The ASIR of lung cancer in Shandong was 42.46 per 100,000 in both sexes (49.19/100,000 in males vs 36.67/100,000 in females). A total of 40,626 lung cancer-specific deaths were ascertained (28,185 men and 12,441 women). The ASMR was 19.76/100,000 in both sexes, 26.29/100,000 and 11.38/100,000 in males and females, respectively. The IQR of county-level ASIR and ASMR were 17.13/100,000 and 10.41/100,000, respectively. The inequality was primarily due to within-municipality disparities, with within-municipality Theil T indices higher than between-municipality Theil T indices (0.0572 vs 0.0033 for ASIR, 0.0824 vs 0.0011 for ASMR). Conclusions: The cancer surveillance approach based on linked administrative data could provide up-to-date small-area estimates of cancer burden, when cancer registry data are not yet reported and for areas not covered by cancer registries. It could reveal disparity of cancer epidemiology, which provides leads for further investigation into the underlying causes and potential solutions for equity improvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.